,Chapter %rg1 %rgCellular %rgFunction
1. An %rgincrease %rgin %rgcardiac %rgsize %rgand %rgfunction %rgdue %rgto %rgincreased %rgworkload
%rgis %rgtermed
A) Atrophy.
B) Functional.
C) Hypertrophy.
D) Inflammation.
2. While %rgassessing %rga %rgpatient %rgdiagnosed %rgwith %rgMarfan's %rgSyndrome, %rgthe
%rgnurse %rgshould %rginclude %rgwhich %rgof %rgthe %rgfollowing %rgthat %rgis %rgconsistent %rgwith
%rgthe %rgsyndrome?
A) Cardiac %rgassessment %rgfor %rgcoarctation %rg of %rgthe %rg aorta.
B) Genital %rgassessment %rgfor %rgsmall %rgtesticles.
C) Mental %rg assessment %rg for %rg impairment.
D) Oral %rgassessment %rgfor %rgcleft %rgpalate.
3. Children %rgwith %rgPKU %rgmust %rgavoid %rgphenylalanine %rgin %rgthe %rgdiet.
%rgPhenylalanine %rgis %rgmost %rglikely %rgto %rgbe %rga %rgcomponent %rgof
A) Fat.
B) Sugar.
C) Protein.
D) Carbohydrate.
4. A %rg17-year-old %rgcollege-bound %rgstudent %rgreceives %rga %rgvaccine %rgagainst %rgan
%rgorganism %rgthat %rgcauses %rgmeningitis. %rgThis %rgis %rgan %rgexample %rgof
A) primary %rgprevention.
B) secondary %rgprevention.
C) tertiary %rgprevention.
D) disease %rg treatment.
5. Metaplasia %rgis
A) The %rgdisorganization %rg of %rgcells %rginto %rgvarious %rgsizes, %rgshapes, %rgand
%rg arrangements.
B) The %rgreplacement %rgof %rgone %rgdifferentiated %rgcell %rgtype %rgwith %rganother.
C) The %rgtransformation %rgof %rga %rgcell %rgtype %rgto %rg malignancy.
D) An %rgirreversible %rgcellular %rg adaptation.
, 6. During %rga %rgroutine %rgultrasound %rgof %rga %rg38 %rgyear %rgold %rgwomen %rg26 %rgweeks
%rggestation %rgreveals %rga %rgfetus %rgwith %rga %rgsmall %rgsquare %rghead, %rgupward %rgslant
%rgof %rgthe %rgeyes, %rgand %rglow %rgset %rgears. %rgThe %rgnurse %rgrecognizes %rgthat %rgthese
%rgfindings %rgare %rgconsistent %rgwith %rgwhich %rgof %rgthe %rgfollowing?
A) Fragile %rgX %rgSyndrome.
B) Monosomy %rgX %rg(Turner's %rg Syndrome).
C) Trisomy %rg21 %rg (Down's %rgSyndrome).
D) Trisomy %rgX %rg(Klinefelter's %rgSyndrome).
7. While %rgdiscussing %rgtreatment %rgoptions %rgwith %rga %rgparent %rgof %rga %rgnewly
%rgdiagnosed %rgMonosomy %rgX %rg(Turner's %rgSyndrome) %rgchild, %rgthe %rgnurse %rgshould
%rginclude %rgwhich %rgof %rgthe %rgfollowing?
A) There %rgis %rgno %rgtreatment %rg or %rgcure.
B) Symptoms %rgof %rgthe %rgcondition %rg are %rgtreated %rgwith %rgestrogen.
C) Symptoms %rgof %rgthe %rgcondition %rg are %rgtreated %rgwith %rg testosterone.
D) Institutionalization %rgis %rgthe %rgpreferred %rgmethod %rgof %rgmanaging %rg care.
8. Which %rgof %rgthe %rgfollowing %rgassessment %rgfindings %rgindicates %rgan %rgalteration %rgin
%rghomeostatic %rgcontrol %rgmechanisms?
A) Fever
B) Throat %rgpain
C) Joint %rgstiffness
D) Positive %rgthroat %rgculture
9. What %rginformation %rgshould %rgparents %rgbe %rggiven %rgabout %rgthe %rgconsequences %rgof
%rgphenylketonuria %rg(PKU)?
A) Mental %rgretardation %rgis %rginevitable.
B) PKU %rgis %rgcommonly %rgassociated %rg with %rg other %rg congenital %rg anomalies.
C) High %rgdietary %rgtyramine %rgmay %rghelp %rginduce %rg enzyme %rg production.
D) Failure %rg to %rgtreat %rg properly %rgresults %rgin %rgprogressive %rgmental %rg retardation.
10. Injury %rgthat %rgoccurs %rgwhen %rgblood %rgflow %rgis %rgdiminished %rgto %rgtissue %rg is %rgcalled
injury.
A) hypoxic
B) ischemic
C) hyperemic
D) neoplastic
11. Tay %rgsachs %rgis %rgcaused %rgby %rgwhich %rgof %rgthe %rg following?
A) A %rgdeficiency %rgor %rgabsence %rgof %rghexosaminidase %rgA
, B) A %rgdefect %rgon %rgchromosome %rg17 %rgor %rg 22
C) A %rgmutation %rg on %rgchromosome %rg 15
D) An %rgerror %rgin %rgconverting %rgphenylalanine %rg to %rgtyrosine
12. An %rgobese %rgbut %rgotherwise %rghealthy %rgteen %rggoes %rgto %rga %rghealth %rgfair %rgand
%rghas %rgher %rgblood %rgpressure %rgchecked. %rgThis %rgis %rgan %rgexample %rgof
A) primary %rgprevention.
B) secondary %rgprevention.
C) tertiary %rgprevention.
D) disease %rg treatment.
13. Characteristics %rgof %rgX-linked %rgrecessive %rg disorders %rginclude %rg which %rg of %rgthe
%rg following?
A) The %rgson %rgof %rga %rgcarrier %rgmother %rg has %rga %rg 25% %rgchance %rg of %rgbeing %rgaffected.
B) Affected %rgfathers %rgtransmit %rgthe %rggene %rgto %rgall %rgof %rgtheir %rgsons.
C) All %rgdaughters %rgof %rgaffected %rgfathers %rgare %rgcarriers.
D) Boys %rgand %rggirls %rgare %rgequally %rgaffected.
14. A %rgfactor %rgassociated %rgwith %rgrisk %rgof %rgDown %rgsyndrome %rgis
A) Maternal %rgage.
B) Maternal %rgalcohol %rgintake.
C) Family %rghistory %rgof %rgheritable %rg diseases.
D) Exposure %rgto %rgTORCH %rgsyndrome %rg organisms.
15. Which %rgtype %rgof %rggangrene %rgis %rgusually %rga %rgresult %rgof %rgarterial %rgocclusion?
A) Necrosis.
B) Dry.
C) Wet.
D) Gas.
16. The %rgcancer %rggrowth %rgcontinuum %rgis %rgdivided %rginto %rgthe %rgfollowing %rgstages.
A) Stage %rg1, %rgStage %rg2, %rgStage %rg3
B) Initiation, %rgProgression, %rgPromotion
C) Preliminary, %rgEvolutionary, %rgMetastasis
D) Initiation, %rgPromotion, %rgProgression
17. A %rgdisease %rgin %rgwhich %rgthe %rgprincipal %rgmanifestation %rgis %rgan %rgabnormal
%rggrowth %rgof %rgcells %rgleading %rgto %rgformation %rgof %rgtumors %rgis %rgcalled %rga
1. An %rgincrease %rgin %rgcardiac %rgsize %rgand %rgfunction %rgdue %rgto %rgincreased %rgworkload
%rgis %rgtermed
A) Atrophy.
B) Functional.
C) Hypertrophy.
D) Inflammation.
2. While %rgassessing %rga %rgpatient %rgdiagnosed %rgwith %rgMarfan's %rgSyndrome, %rgthe
%rgnurse %rgshould %rginclude %rgwhich %rgof %rgthe %rgfollowing %rgthat %rgis %rgconsistent %rgwith
%rgthe %rgsyndrome?
A) Cardiac %rgassessment %rgfor %rgcoarctation %rg of %rgthe %rg aorta.
B) Genital %rgassessment %rgfor %rgsmall %rgtesticles.
C) Mental %rg assessment %rg for %rg impairment.
D) Oral %rgassessment %rgfor %rgcleft %rgpalate.
3. Children %rgwith %rgPKU %rgmust %rgavoid %rgphenylalanine %rgin %rgthe %rgdiet.
%rgPhenylalanine %rgis %rgmost %rglikely %rgto %rgbe %rga %rgcomponent %rgof
A) Fat.
B) Sugar.
C) Protein.
D) Carbohydrate.
4. A %rg17-year-old %rgcollege-bound %rgstudent %rgreceives %rga %rgvaccine %rgagainst %rgan
%rgorganism %rgthat %rgcauses %rgmeningitis. %rgThis %rgis %rgan %rgexample %rgof
A) primary %rgprevention.
B) secondary %rgprevention.
C) tertiary %rgprevention.
D) disease %rg treatment.
5. Metaplasia %rgis
A) The %rgdisorganization %rg of %rgcells %rginto %rgvarious %rgsizes, %rgshapes, %rgand
%rg arrangements.
B) The %rgreplacement %rgof %rgone %rgdifferentiated %rgcell %rgtype %rgwith %rganother.
C) The %rgtransformation %rgof %rga %rgcell %rgtype %rgto %rg malignancy.
D) An %rgirreversible %rgcellular %rg adaptation.
, 6. During %rga %rgroutine %rgultrasound %rgof %rga %rg38 %rgyear %rgold %rgwomen %rg26 %rgweeks
%rggestation %rgreveals %rga %rgfetus %rgwith %rga %rgsmall %rgsquare %rghead, %rgupward %rgslant
%rgof %rgthe %rgeyes, %rgand %rglow %rgset %rgears. %rgThe %rgnurse %rgrecognizes %rgthat %rgthese
%rgfindings %rgare %rgconsistent %rgwith %rgwhich %rgof %rgthe %rgfollowing?
A) Fragile %rgX %rgSyndrome.
B) Monosomy %rgX %rg(Turner's %rg Syndrome).
C) Trisomy %rg21 %rg (Down's %rgSyndrome).
D) Trisomy %rgX %rg(Klinefelter's %rgSyndrome).
7. While %rgdiscussing %rgtreatment %rgoptions %rgwith %rga %rgparent %rgof %rga %rgnewly
%rgdiagnosed %rgMonosomy %rgX %rg(Turner's %rgSyndrome) %rgchild, %rgthe %rgnurse %rgshould
%rginclude %rgwhich %rgof %rgthe %rgfollowing?
A) There %rgis %rgno %rgtreatment %rg or %rgcure.
B) Symptoms %rgof %rgthe %rgcondition %rg are %rgtreated %rgwith %rgestrogen.
C) Symptoms %rgof %rgthe %rgcondition %rg are %rgtreated %rgwith %rg testosterone.
D) Institutionalization %rgis %rgthe %rgpreferred %rgmethod %rgof %rgmanaging %rg care.
8. Which %rgof %rgthe %rgfollowing %rgassessment %rgfindings %rgindicates %rgan %rgalteration %rgin
%rghomeostatic %rgcontrol %rgmechanisms?
A) Fever
B) Throat %rgpain
C) Joint %rgstiffness
D) Positive %rgthroat %rgculture
9. What %rginformation %rgshould %rgparents %rgbe %rggiven %rgabout %rgthe %rgconsequences %rgof
%rgphenylketonuria %rg(PKU)?
A) Mental %rgretardation %rgis %rginevitable.
B) PKU %rgis %rgcommonly %rgassociated %rg with %rg other %rg congenital %rg anomalies.
C) High %rgdietary %rgtyramine %rgmay %rghelp %rginduce %rg enzyme %rg production.
D) Failure %rg to %rgtreat %rg properly %rgresults %rgin %rgprogressive %rgmental %rg retardation.
10. Injury %rgthat %rgoccurs %rgwhen %rgblood %rgflow %rgis %rgdiminished %rgto %rgtissue %rg is %rgcalled
injury.
A) hypoxic
B) ischemic
C) hyperemic
D) neoplastic
11. Tay %rgsachs %rgis %rgcaused %rgby %rgwhich %rgof %rgthe %rg following?
A) A %rgdeficiency %rgor %rgabsence %rgof %rghexosaminidase %rgA
, B) A %rgdefect %rgon %rgchromosome %rg17 %rgor %rg 22
C) A %rgmutation %rg on %rgchromosome %rg 15
D) An %rgerror %rgin %rgconverting %rgphenylalanine %rg to %rgtyrosine
12. An %rgobese %rgbut %rgotherwise %rghealthy %rgteen %rggoes %rgto %rga %rghealth %rgfair %rgand
%rghas %rgher %rgblood %rgpressure %rgchecked. %rgThis %rgis %rgan %rgexample %rgof
A) primary %rgprevention.
B) secondary %rgprevention.
C) tertiary %rgprevention.
D) disease %rg treatment.
13. Characteristics %rgof %rgX-linked %rgrecessive %rg disorders %rginclude %rg which %rg of %rgthe
%rg following?
A) The %rgson %rgof %rga %rgcarrier %rgmother %rg has %rga %rg 25% %rgchance %rg of %rgbeing %rgaffected.
B) Affected %rgfathers %rgtransmit %rgthe %rggene %rgto %rgall %rgof %rgtheir %rgsons.
C) All %rgdaughters %rgof %rgaffected %rgfathers %rgare %rgcarriers.
D) Boys %rgand %rggirls %rgare %rgequally %rgaffected.
14. A %rgfactor %rgassociated %rgwith %rgrisk %rgof %rgDown %rgsyndrome %rgis
A) Maternal %rgage.
B) Maternal %rgalcohol %rgintake.
C) Family %rghistory %rgof %rgheritable %rg diseases.
D) Exposure %rgto %rgTORCH %rgsyndrome %rg organisms.
15. Which %rgtype %rgof %rggangrene %rgis %rgusually %rga %rgresult %rgof %rgarterial %rgocclusion?
A) Necrosis.
B) Dry.
C) Wet.
D) Gas.
16. The %rgcancer %rggrowth %rgcontinuum %rgis %rgdivided %rginto %rgthe %rgfollowing %rgstages.
A) Stage %rg1, %rgStage %rg2, %rgStage %rg3
B) Initiation, %rgProgression, %rgPromotion
C) Preliminary, %rgEvolutionary, %rgMetastasis
D) Initiation, %rgPromotion, %rgProgression
17. A %rgdisease %rgin %rgwhich %rgthe %rgprincipal %rgmanifestation %rgis %rgan %rgabnormal
%rggrowth %rgof %rgcells %rgleading %rgto %rgformation %rgof %rgtumors %rgis %rgcalled %rga
